Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

阿昔替尼片 - NMPA Drug Approval Details

Approvals/NMPA/Axitinib Tablets

Approved

化学药品

Axitinib Tablets

广州科锐特药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Apr 14, 2026
Approval ID: 8n5SSVU6S12
Company: 广州科锐特药业有限公司
Type: 化学药品

Approval Details

Approval Id: 8n5SSVU6S12
Approval Number: 国药准字H20263989
Generic Name: 阿昔替尼片
Generic Name En: Axitinib Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 5mg
Reg Date: 2026-04-14
Company Name: 广州科锐特药业有限公司
Company Address: 广州市黄埔区春分路80号
Production Company Name: 广州科锐特药业有限公司
Production Company Address: 广州市黄埔区春分路80号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 14, 2026

Approval ID

8n5SSVU6S12

Type

化学药品

Back to NMPA Approvals